Secure drug reimbursement by demonstrating Lilly product value through the full reimbursement lifecycle
Develop best-in-class HTA dossiers including health economics and budget impact analyses for submissions
Lead price negotiations with Korean government authorities on new drug approval,price-volume negotiation,RSA reassessment,and reimbursement expansion
What they want
Experience in pharmaceutical market access,HTA submissions,and payer marketing strategy
Ability to develop and implement pricing and reimbursement strategies from launch through post-launch
Understanding of HEOR,pharmacoeconomic modeling,and budget impact analysis
Nice to have
Experience with Korean-specific government negotiations (NHIS,HIRA)
Participation in trade associations or policy initiatives
Experience managing vendor contracts for health economics studies
Seoulstart's read
Visa tier (likely)
F-2 / F-4 / F-5 / F-6 holders welcome
Korean language
Business-level Korean required
English friendliness
High: JD in English, foreign-friendly signals
Context
High-stakes market access role at Eli Lilly Korea,interfacing directly with Korean government (NHIS,HIRA) for drug reimbursement negotiations -- one of the most specialized pharma roles in Korea requiring deep knowledge of Korea's government-controlled pharmaceutical pricing system
This is Seoulstart's analysis of the public job description, not the employer's stated policy. Verify visa sponsorship, language requirements, and remote allowances directly with the recruiter.